Use of hormonal contraceptives and risk of <font color="red">HIV-1_1</font> transmission : a prospective cohort study . 
<br>
<br> BACKGROUND Hormonal contraceptives are used widely but their effects on HIV-1 risk are unclear . We aimed to assess the association between hormonal contraceptive use and risk of <font color="red">HIV-1_1</font> <font color="red">acquisition_1</font> <font color="red">by_1</font> <font color="red">women_1</font> <font color="red">and_1</font> <font color="red">HIV-1_1</font> <font color="red">transmission_1</font> <font color="red">from_1</font> <font color="red">HIV-1-infected_1</font> <font color="red">women_1</font> <font color="red">to_1</font> <font color="red">their_1</font> <font color="red">male_1</font> <font color="red">partners_1</font> <font color="red">._1</font> 
<br> METHODS In this prospective study , <font color="red">we_1</font> <font color="red">followed_1</font> <font color="red">up_1</font> <font color="red">3790_5</font> <font color="red">heterosexual_5</font> <font color="red">HIV-1-serodiscordant_5</font> <font color="red">couples_5</font> <font color="red">participating_5</font> <font color="red">in_5</font> <font color="red">two_5</font> <font color="red">longitudinal_5</font> <font color="red">studies_5</font> <font color="red">of_5</font> <font color="red">HIV-1_5</font> <font color="red">incidence_5</font> <font color="red">in_5</font> <font color="red">seven_5</font> <font color="red">African_5</font> <font color="red">countries_5</font> <font color="red">._5</font> Among injectable and oral hormonal contraceptive users and non - users , we compared rates of HIV-1 acquisition by women and HIV-1 transmission from women to men . The primary outcome measure was HIV-1 seroconversion . We used Cox <font color="red">proportional_1</font> <font color="red">hazards_1</font> <font color="red">regression_1</font> <font color="red">and_1</font> <font color="red">marginal_1</font> <font color="red">structural_1</font> <font color="red">modelling_1</font> <font color="red">to_1</font> <font color="red">assess_1</font> <font color="red">the_1</font> <font color="red">effect_1</font> <font color="red">of_1</font> <font color="red">contraceptive_1</font> <font color="red">use_1</font> <font color="red">on_1</font> <font color="red">HIV-1_1</font> <font color="red">risk_1</font> <font color="red">._1</font> <font color="red">
<br>_1</font> <font color="red">FINDINGS_1</font> <font color="red">Among_1</font> <font color="red">1314_4</font> <font color="red">couples_4</font> <font color="red">in_4</font> <font color="red">which_4</font> <font color="red">the_4</font> <font color="red">HIV-1-seronegative_4</font> <font color="red">partner_4</font> <font color="red">was_4</font> <font color="red">female_4</font> <font color="red">(_3</font> <font color="red">median_3</font> <font color="red">follow_3</font> <font color="red">-_3</font> <font color="red">up_3</font> <font color="red">18·0_3</font> <font color="red">[_3</font> <font color="red">IQR_3</font> <font color="red">12·6_3</font> <font color="red">-_3</font> <font color="red">24·2_3</font> <font color="red">]_3</font> <font color="red">months_3</font> <font color="red">)_3</font> <font color="red">,_3</font> <font color="red">rates_2</font> <font color="red">of_2</font> <font color="red">HIV-1_2</font> <font color="red">acquisition_2</font> <font color="red">were_2</font> <font color="red">6·61_2</font> <font color="red">per_2</font> <font color="red">100_2</font> <font color="red">person_2</font> <font color="red">-_2</font> <font color="red">years_2</font> <font color="red">in_2</font> <font color="red">women_2</font> <font color="red">who_2</font> <font color="red">used_2</font> <font color="red">hormonal_2</font> <font color="red">contraception_2</font> <font color="red">and_2</font> <font color="red">3·78_2</font> <font color="red">per_2</font> <font color="red">100_2</font> <font color="red">person_2</font> <font color="red">-_2</font> <font color="red">years_2</font> <font color="red">in_2</font> <font color="red">those_2</font> <font color="red">who_2</font> <font color="red">did_2</font> <font color="red">not_2</font> <font color="red">(_2</font> <font color="red">adjusted_2</font> <font color="red">hazard_2</font> <font color="red">ratio_2</font> <font color="red">1·98_2</font> <font color="red">,_2</font> <font color="red">95%_2</font> <font color="red">CI_2</font> <font color="red">1·06_2</font> <font color="red">-_2</font> <font color="red">3·68_2</font> <font color="red">,_2</font> <font color="red">p=0·03_2</font> <font color="red">)_2</font> . Among <font color="red">2476_2</font> <font color="red">couples_2</font> <font color="red">in_2</font> <font color="red">which_2</font> <font color="red">the_2</font> <font color="red">HIV-1-seronegative_2</font> <font color="red">partner_2</font> <font color="red">was_2</font> <font color="red">male_2</font> <font color="red">(_1</font> <font color="red">median_1</font> <font color="red">follow_1</font> <font color="red">-_1</font> <font color="red">up_1</font> <font color="red">18·7_1</font> <font color="red">[_1</font> <font color="red">IQR_1</font> <font color="red">12·8_1</font> <font color="red">-_1</font> <font color="red">24·2_1</font> <font color="red">]_1</font> <font color="red">months_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">rates_1</font> <font color="red">of_1</font> <font color="red">HIV-1_1</font> <font color="red">transmission_1</font> <font color="red">from_1</font> <font color="red">women_1</font> <font color="red">to_1</font> <font color="red">men_1</font> <font color="red">were_1</font> <font color="red">2·61_1</font> <font color="red">per_1</font> <font color="red">100_1</font> <font color="red">person_1</font> <font color="red">-_1</font> <font color="red">years_1</font> <font color="red">in_1</font> <font color="red">couples_1</font> <font color="red">in_1</font> <font color="red">which_1</font> <font color="red">women_1</font> <font color="red">used_1</font> <font color="red">hormonal_1</font> <font color="red">contraception_1</font> <font color="red">and_1</font> <font color="red">1·51_1</font> <font color="red">per_1</font> <font color="red">100_1</font> <font color="red">person_1</font> <font color="red">-_1</font> <font color="red">years_1</font> <font color="red">in_1</font> <font color="red">couples_1</font> <font color="red">in_1</font> <font color="red">which_1</font> <font color="red">women_1</font> <font color="red">did_1</font> <font color="red">not_1</font> <font color="red">use_1</font> <font color="red">hormonal_1</font> <font color="red">contraception_1</font> <font color="red">(_1</font> <font color="red">adjusted_1</font> <font color="red">hazard_1</font> <font color="red">ratio_1</font> <font color="red">1·97_1</font> <font color="red">,_1</font> <font color="red">95%_1</font> <font color="red">CI_1</font> <font color="red">1·12_1</font> <font color="red">-_1</font> <font color="red">3·45_1</font> <font color="red">,_1</font> <font color="red">p=0·02_1</font> <font color="red">)_1</font> <font color="red">._1</font> Marginal structural model analyses generated much the same results to the Cox proportional hazards regression . 
<br> INTERPRETATION Women should be counselled about potentially increased risk of HIV-1 acquisition and transmission with hormonal contraception , especially injectable methods , and about the importance of dual protection with condoms to decrease HIV-1 risk . Non - hormonal or low - dose hormonal contraceptive methods should be considered for women with or at - risk for HIV-1 . 
<br> FUNDING US National Institutes of Health and the Bill & Melinda Gates Foundation .